Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

23.03
Delayed Data
As of Aug 23
 +4.93 / +27.24%
Today’s Change
11.57
Today|||52-Week Range
116.75
-34.20%
Year-to-Date

Today’s Trading

Previous close18.10
Today’s open18.30
Day’s range16.61 - 24.97
Volume17,497,413
Average volume (3 months)1,206,003
Market cap$696.9M
Dividend yield--
Data as of 4:00pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+7.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.01-0.05%
GBTGlobal Blood Therape...-0.10-0.51%
MACKMerrimack Pharmaceut...+0.13+2.53%
DVAXDynavax Technologies...+0.11+0.66%
Data as of 4:00pm ET, 08/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$2.01
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs